Single-molecule characterization of oligomerization kinetics and equilibria of the tumor suppressor p53

Nucleic Acids Research

Volumn 39, Issue 6, 2011, Pages 2294-2303

  Rajagopalan, Sridharan ^a,c   Huang, Fang ^a,b   Fersht, Alan R ^a  

^a MRC CENTRE FOR PROTEIN ENGINEERING   (United Kingdom)

^b CHINA UNIVERSITY OF PETROLEUM   (China)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ARTICLE; BINDING AFFINITY; CHEMICAL REACTION KINETICS; CONTROLLED STUDY; DNA BINDING; IONIC STRENGTH; MUTATION; OLIGOMERIZATION; PH; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN FUNCTION; PROTEIN ISOLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; TEMPERATURE; TUMOR CELL;

DIMERIZATION; DNA; KINETICS; PROTEIN MULTIMERIZATION; SPECTROMETRY, FLUORESCENCE; THERMODYNAMICS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 79953723488     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkq800     Document Type: Article

References (41)

1. Vousden,K.H. and Prives,C. (2009) Blinded by the light: the growing complexity of p53. Cell, 137, 413-431.
2. Tidow,H., Melero,R., Mylonas,E., Freund,S.M., Grossmann,J.G., Carazo,J.M., Svergun,D.I., Valle,M. and Fersht,A.R. (2007) Quaternary structures of tumor suppressor p53 and a specific p53 DNA complex. Proc. Natl Acad. Sci. USA, 104, 12324-12329.
3. Petitjean,A., Mathe,E., Kato,S., Ishioka,C., Tavtigian,S.V., Hainaut,P. and Olivier,M. (2007) Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database. Hum. Mutat., 28, 622-629.
4. Nicholls,C.D., McLure,K.G., Shields,M.A. and Lee,P.W. (2002) Biogenesis of p53 involves cotranslational dimerization of monomers and posttranslational dimerization of dimers. Implications on the dominant negative effect. J. Biol. Chem., 277, 12937-12945.
5. Varley,J.M., McGown,G., Thorncroft,M., Cochrane,S., Morrison,P., Woll,P., Kelsey,A.M., Mitchell,E.L., Boyle,J., Birch,J.M. et al. (1996) A previously undescribed mutation within the tetramerisation domain of TP53 in a family with Li-Fraumeni syndrome. Oncogene, 12, 2437-2442. (Pubitemid 26192725)
6. Weinberg,R.L., Veprintsev,D.B. and Fersht,A.R. (2004) Cooperative binding of tetrameric p53 to DNA. J. Mol. Biol., 341, 1145-1159.
7. McLure,K.G. and Lee,P.W. (1998) How p53 binds DNA as a tetramer. EMBO J., 17, 3342-3350. (Pubitemid 28279508)
8. Chene,P. and Jahnke,W. (2002) Oligomerization of p53 upon cooperative DNA binding: towards a structural understanding of p53 function. Angew Chem. Int. Ed. Engl, 41, 1702-1704.
9. Stenger,J.E., Tegtmeyer,P., Mayr,G.A., Reed,M., Wang,Y., Wang,P., Hough,P.V. and Mastrangelo,I.A. (1994) p53 oligomerization and DNA looping are linked with transcriptional activation. EMBO J., 13, 6011-6020.
10. Itahana,Y., Ke,H. and Zhang,Y. (2009) p53 Oligomerization is essential for its C-terminal lysine acetylation. J. Biol. Chem., 284, 5158-5164.
11. Maki,C.G. (1999) Oligomerization is required for p53 to be efficiently ubiquitinated by MDM2. J. Biol. Chem., 274, 16531-16535.
12. Shieh,S.Y., Taya,Y. and Prives,C. (1999) DNA damage-inducible phosphorylation of p53 at N-terminal sites including a novel site, Ser20, requires tetramerization. EMBO J., 18, 1815-1823. (Pubitemid 29158525)
13. Mateu,M.G., Sanchez Del Pino,M.M. and Fersht,A.R. (1999) Mechanism of folding and assembly of a small tetrameric protein domain from tumor suppressor p53. Nat. Struct. Biol., 6, 191-198.
14. Brandt,T., Petrovich,M., Joerger,A.C. and Veprintsev,D.B. (2009) Conservation of DNA-binding specificity and oligomerisation properties within the p53 family. BMC Genomics, 10, 628.
15. Natan,E., Hirschberg,D., Morgner,N., Robinson,C.V. and Fersht,A.R. (2009) Ultraslow oligomerization equilibria of p53 and its implications. Proc. Natl Acad. Sci. USA, 106, 14327-14332.
16. Rajagopalan,S., Jaulent,A.M., Wells,M., Veprintsev,D.B. and Fersht,A.R. (2008) 14-3-3 activation of DNA binding of p53 by enhancing its association into tetramers. Nucleic Acids Res., 36, 5983-5991.
17. Rajagopalan,S., Andreeva,A., Teufel,D.P., Freund,S.M. and Fersht,A.R. (2009) Interaction between the transactivation domain of p53 and PC4 exemplifies acidic activation domains as single-stranded DNA mimics. J. Biol. Chem., 284, 21728-21737.
18. Huang,F., Rajagopalan,S., Settanni,G., Marsh,R.J., Armoogum,D.A., Nicolaou,N., Bain,A.J., Lerner,E., Haas,E., Ying,L. et al. (2009) Multiple conformations of full-length p53 detected with single-molecule fluorescence resonance energy transfer. Proc. Natl Acad. Sci. USA, 106, 20758-20763.
19. Neuweiler,H., Johnson,C.M. and Fersht,A.R. (2009) Direct observation of ultrafast folding and denatured state dynamics in single protein molecules. Proc. Natl Acad. Sci. USA, 106, 18569-18574.
20. Meseth,U., Wohland,T., Rigler,R. and Vogel,H. (1999) Resolution of fluorescence correlation measurements. Biophys. J., 76, 1619-1631.
21. Muller,J.D., Chen,Y. and Gratton,E. (2003) Fluorescence correlation spectroscopy. Methods Enzymol., 361, 69-92. (Pubitemid 36240995)
22. Schwille,P. (2001) Fluorescence correlation spectroscopy and its potential for intracellular applications. Cell. Biochem. Biophys., 34, 383-408.
23. Berland,K.M. (2004) Fluorescence correlation spectroscopy: a new tool for quantification of molecular interactions. Methods Mol. Biol., 261, 383-398.
24. Rigler,R. (1995) Fluorescence correlations, single molecule detection and large number screening. Applications in biotechnology. J. Biotechnol., 41, 177-186.
25. Doose,S., Neuweiler,H., Barsch,H. and Sauer,M. (2007) Probing polyproline structure and dynamics by photoinduced electron transfer provides evidence for deviations from a regular polyproline type II helix. Proc. Natl Acad. Sci. USA, 104, 17400-17405.
26. Rauer,B., Neumann,E., Widengren,J. and Rigler,R. (1996) Fluorescence correlation spectrometry of the interaction kinetics of tetramethylrhodamin alpha-bungarotoxin with Torpedo californica acetylcholine receptor. Biophys. Chem., 58, 3-12.
27. Friedler,A., Veprintsev,D.B., Hansson,L.O. and Fersht,A.R. (2003) Kinetic instability of p53 core domain mutants: implications for rescue by small molecules. J. Biol. Chem., 278, 24108-24112.
28. Nikolova,P.V., Henckel,J., Lane,D.P. and Fersht,A.R. (1998) Semirational design of active tumor suppressor p53 DNA binding domain with enhanced stability. Proc. Natl Acad. Sci. USA, 95, 14675-14680.
29. Joerger,A.C., Ang,H.C. and Fersht,A.R. (2006) Structural basis for understanding oncogenic p53 mutations and designing rescue drugs. Proc. Natl Acad. Sci. USA, 103, 15056-15061.
30. Ruttinger,S., Buschmann,V., Kramer,B., Erdmann,R., Macdonald,R. and Koberling,F. (2008) Comparison and accuracy of methods to determine the confocal volume for quantitative fluorescence correlation spectroscopy. J. Microsc., 232, 343-352.
31. Godoy-Ruiz,R., Ariza,F., Rodriguez-Larrea,D., Perez-Jimenez,R., Ibarra-Molero,B. and Sanchez-Ruiz,J.M. (2006) Natural selection for kinetic stability is a likely origin of correlations between mutational effects on protein energetics and frequencies of amino acid occurrences in sequence alignments. J. Mol. Biol., 362, 966-978.
32. Davison,T.S., Nie,X., Ma,W., Lin,Y., Kay,C., Benchimol,S. and Arrowsmith,C.H. (2001) Structure and functionality of a designed p53 dimer. J. Mol. Biol., 307, 605-617.
33. Ang,H.C., Joerger,A.C., Mayer,S. and Fersht,A.R. (2006) Effects of common cancer mutations on stability and DNA binding of full-length p53 compared with isolated core domains. J. Biol. Chem., 281, 21934-21941.
34. Sakaguchi,K., Sakamoto,H., Lewis,M.S., Anderson,C.W., Erickson,J.W., Appella,E. and Xie,D. (1997) Phosphorylation of serine 392 stabilizes the tetramer formation of tumor suppressor protein p53. Biochemistry, 36, 10117-10124. (Pubitemid 27357721)
35. Veprintsev,D.B., Freund,S.M., Andreeva,A., Rutledge,S.E., Tidow,H., Canadillas,J.M., Blair,C.M. and Fersht,A.R. (2006) Core domain interactions in full-length p53 in solution. Proc. Natl Acad. Sci. USA, 103, 2115-2119.
36. Kaeser,M.D. and Iggo,R.D. (2002) Chromatin immunoprecipitation analysis fails to support the latency model for regulation of p53 DNA binding activity in vivo. Proc. Natl Acad. Sci. USA, 99, 95-100.
37. Rajagopalan,S., Sade,R.S., Townsley,F.M. and Fersht,A.R. (2010) Mechanistic differences in the transcriptional activation of p53 by 14-3-3 isoforms. Nucleic Acids Res., 38, 893-906.
38. Kruse,J.P. and Gu,W. (2009) Modes of p53 regulation. Cell, 137, 609-622.
39. Fernandez-Fernandez,M.R., Veprintsev,D.B. and Fersht,A.R. (2005) Proteins of the S100 family regulate the oligomerization of p53 tumor suppressor. Proc. Natl Acad. Sci. USA, 102, 4735-4740.
40. van Dieck,J., Fernandez-Fernandez,M.R., Veprintsev,D.B. and Fersht,A.R. (2009) Modulation of the oligomerization state of p53 by differential binding of proteins of the S100 family to p53 monomers and tetramers. J. Biol. Chem., 284, 13804-13811.
41. Lin,J., Blake,M., Tang,C., Zimmer,D., Rustandi,R.R., Weber,D.J. and Carrier,F. (2001) Inhibition of p53 transcriptional activity by the S100B calcium-binding protein. J. Biol. Chem., 276, 35037-35041.